The Attractiveness of Investing In BeiGene Ltd. (BGNE) is Growing


In a filing, BeiGene Ltd. revealed its SVP, General Counsel Lee Chan Henry unloaded Company’s shares for reported $0.17 million on Jul 31. In the deal valued at $216.26 per share,791 shares were sold. As a result of this transaction, Lee Chan Henry now holds 0 shares worth roughly $ 0.0.

Top 5 EV Tech Stocks to Buy for 2023

The electric vehicle boom is accelerating – and fast. According a new report published by BloombergNEF, annual spending on passenger EVs hit $388 billion in 2022, up 53% from the year before. Like we said, the boom is accelerating – and the time to buy EV-related tech stocks is now. Get our free report, "Top 5 EV Tech Stocks to Buy for 2023".

Click Here to Download the FREE Report.


Then, Wang Julia Aijun sold 472 shares, generating $84,747 in total proceeds. Upon selling the shares at $179.55, the Chief Financial Officer now owns 0 shares.

Before that, Wu Xiaobin sold 1,495 shares. BeiGene Ltd. shares valued at $272,636 were divested by the President, COO & GM China at a price of $182.37 per share. As a result of the transaction, Wu Xiaobin now holds 0 shares, worth roughly $0.0.

Jefferies initiated its BeiGene Ltd. [BGNE] rating to a Buy in a research note published on Friday, August 17, 2023; the price target was $287. PT values the company’s stock at a premium of 27.21 to its Friday closing price.

Price Performance Review of BGNE

On Friday, BeiGene Ltd. [NASDAQ:BGNE] saw its stock jump 0.66% to $208.92. On the same session, the stock had its day’s lowest price of $207.58, but rose to a high of $213.38. Over the last five days, the stock has gained 5.30%. BeiGene Ltd. shares have fallen nearly -5.01% since the year began. Nevertheless, the stocks have risen 21.71% over the past one year. While a 52-week high of $280.62 was reached on 01/20/23, a 52-week low of $124.46 was recorded on 06/29/23. SMA at 50 days reached $196.25, while 200 days put it at $221.74. A total of 0.13 million shares were traded, compared to the trading of 0.25 million shares in the previous session.

Levels Of Support And Resistance For BGNE Stock

The 24-hour chart illustrates a support level at 206.54, which if violated will result in even more drops to 204.16. On the upside, there is a resistance level at 212.34. A further resistance level may holdings at 215.76. The Relative Strength Index (RSI) on the 14-day chart is 56.07, which indicates neutral technical sentiment, while the Moving Average Convergence Divergence (MACD) stands at 8.21, which suggests price will go up in the next trading period. Percent R suggests that price movement has been low at 34.50%. Stochastics %K at 66.48% indicates the stock is a holding.

How much short interest is there in BeiGene Ltd.?

A steep rise in short interest was recorded in BeiGene Ltd. stocks on Aug 14, 2023, dropping by 60000.0 shares to a total of 1.73 million shares. Yahoo Finance data shows the prior-month short interest on Jul 13, 2023 was 1.79 million shares. There was a decline of -3.47%, which implies that there is a negative sentiment for the stock.

BeiGene Ltd. [BGNE] – Who Are The Largest Shareholders?

In filings from Baker Bros. Advisors LP, it is revealed that the company now owns 11,668,897 shares, or roughly 12.07% of the outstanding BGNE shares. Additionally, Capital Research & Management Co decreased -4.12% of its stake after which the total value it holdings stand at $1,348,600,374, while HHLR Advisors Ltd. reduced -5.40% of its stake to hold $1.11 billion in the firm. Over the last quarter, PRIMECAP Management Co. sold -31,275 shares of BeiGene Ltd., while Baillie Gifford & Co. sold -34,058 shares. At present, Temasek Holdings Pte Ltd. is holding 3,008,112 shares valued at $644.4 million. Fidelity Management & Research Co owned 2,098,815 shares of the company at the time of its most recent 13F filing, worth $449.61 million.

According to FactSet, BeiGene Ltd.’s share price will average $278.26 in the next year, based on opinions of analysts polled by the firm. This is up nearly 39.36 percent from its previous closing price of $207.55. Analysts expect BeiGene Ltd. stock to reach the higher price of $350.00, while the lowest price estimate is $183.00. However, 26 analysts have rated BGNE stock as a Buy in their predictions for 2023.


Please enter your comment!
Please enter your name here